Pharmaceuticals 2012, 5(9), 963-990; doi:10.3390/ph5090963
Review

Epigenetic Control and Cancer: The Potential of Histone Demethylases as Therapeutic Targets

Center of Biomedical Research La Sabana University-CIBUS, School of Medicine, Universidad de La Sabana, Campus Del Puente del Común, km 7 Autopista Norte de Bogota, Chía 250001, Colombia
* Author to whom correspondence should be addressed.
Received: 26 June 2012; in revised form: 21 July 2012 / Accepted: 17 August 2012 / Published: 12 September 2012
(This article belongs to the Special Issue Epigenetic Therapies and Biomarkers)
PDF Full-text Download PDF Full-Text [617 KB, Updated Version, uploaded 13 September 2012 17:20 CEST]
The original version is still available [653 KB, uploaded 12 September 2012 16:18 CEST]
Abstract: The development of cancer involves an immense number of factors at the molecular level. These factors are associated principally with alterations in the epigenetic mechanisms that regulate gene expression profiles. Studying the effects of chromatin structure alterations, which are caused by the addition/removal of functional groups to specific histone residues, are of great interest as a promising way to identify markers for cancer diagnosis, classify the disease and determine its prognosis, and these markers could be potential targets for the treatment of this disease in its different forms. This manuscript presents the current point of view regarding members of the recently described family of proteins that exhibit histone demethylase activity; histone demethylases are genetic regulators that play a fundamental role in both the activation and repression of genes and whose expression has been observed to increase in many types of cancer. Some fundamental aspects of their association with the development of cancer and their relevance as potential targets for the development of new therapeutic strategies at the epigenetic level are discussed in the following manuscript.
Keywords: neoplasia; epigenomics; histone demethylases; histone demethylases with a jumonji domain

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Lizcano, F.; Garcia, J. Epigenetic Control and Cancer: The Potential of Histone Demethylases as Therapeutic Targets. Pharmaceuticals 2012, 5, 963-990.

AMA Style

Lizcano F, Garcia J. Epigenetic Control and Cancer: The Potential of Histone Demethylases as Therapeutic Targets. Pharmaceuticals. 2012; 5(9):963-990.

Chicago/Turabian Style

Lizcano, Fernando; Garcia, Jeison. 2012. "Epigenetic Control and Cancer: The Potential of Histone Demethylases as Therapeutic Targets." Pharmaceuticals 5, no. 9: 963-990.

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert